Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.01 - Associations Between Baseline Serum Biomarker Levels and Cachexia/Pre-Cachexia in Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients
14:00 - 14:05 | Presenter: Jeffrey Allen Borgia | Author(s): Gabriela C Lobato, Mary Jo Fidler, Jared D Fialkoff, Maneet Multani, Conner Wakefield, Sanjib Basu, Marta Batus, Philip Bonomi
- Abstract
Loading... -
+
MA13.02 - Incidence of Venous Thromboembolism at the Time of Lung Cancer Diagnosis: A Multicenter, Prospective Observational Trial (Rising-VTE/NEJ037)
14:05 - 14:10 | Presenter: Kosuke Hamai | Author(s): Yukari Tsubata, Naoki Furuya, Tae Hata, Ryota Saito, Takeshi Masuda, Takamasa Hotta, Megumi Hamaguchi, Shoichi Kuyama, Ryoichi Honda, Kikuo Nakano, Masamoto Nakanishi, Kunihiko Funaishi, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe
- Abstract
Loading... -
+
MA13.03 - Retrospective Study of Intrathecal Therapy for Non-Small Cell Lung Cancer (NSCLC) Patients with Leptomeningeal Carcinomatosis
14:10 - 14:15 | Presenter: Noelia Vilariño | Author(s): Juan Antonio Marín, Marta Simó, Roser Velasco, Montserrat Alemany, Maria Jove, Jose Carlos Ruffinelli, Isabel Brao, Monica Arellano, Ramon Palmero Sánchez, Jordi Bruna, Ernest Nadal
- Abstract
Loading... -
+
MA13.04 - Discussant - MA13.01, MA13.02, MA13.03
14:15 - 14:30 | Presenter: Ramaswamy Govindan
- Abstract
No abstract available for this presentation
-
+
MA13.05 - Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study
14:30 - 14:35 | Presenter: David R Spigel | Author(s): Robert M Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Michael McCleod, Mark A Socinski, Davey Daniel, Oscar Juan, Kathryn F Mileham, HOWARD WEST, Ray Page, Niels Reinmuth, Jeanna Knoble, Olivia Yu Tian, Rafia Bhore, Marianne Wolfsteiner, Teng Jin Ong, Cesare Gridelli, Michael Thomas
- Abstract
Loading... -
+
MA13.06 - Ph3 Study of Maintenance Therapy with S-1 vs BSC After Induction Therapy with Carboplatin + S-1 for Advanced Squamous Cell Lung Cancer (WJOG7512L)
14:35 - 14:40 | Presenter: Kaoru Tanaka | Author(s): Satoshi Morita, Masahiko Ando, Takuma Yokoyama, Atsushi Nakamura, Hiroshige Yoshioka, Takashi Ishiguro, Satoru Miura, Ryo Toyozawa, Tetsuya Oguri, Haruko Daga, Ryo Ko, Akihiro Bessho, Motoko Tachihara, Yasuo Iwamoto, Katsuya Hirano, Yoichi Nakanishi, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Isamu Okamoto
- Abstract
Loading... -
+
MA13.07 - Phase I/II Study of Carboplatin Plus Weekly Nab-Paclitaxel in Aged ≥75 Patients with Squamous-Cell Lung Cancer: TORG1322
14:40 - 14:45 | Presenter: Yoshitaka Zenke | Author(s): Seiji Niho, Shigeki Umemura, Masashi Ishihara, Ryosuke Ochiai, Naoyuki Nogami, Yukio Hosomi, Tsuneo Shimokawa, Takaaki Tokito, Yasushi Goto, Yosuke Miura, Haruhiro Saito, Naoya Hida, Satoshi Ikeda, Hiroshi Tanaka, Naoki Furuya, Toshihiro Misumi, Yuichiro Ohe, Hiroaki Okamoto
- Abstract
Loading... -
+
MA13.08 - Discussant - MA13.05, MA13.06, MA13.07
14:45 - 15:00 | Presenter: Karen L Reckamp
- Abstract
No abstract available for this presentation
-
+
MA13.09 - Cisplatin Sustains Lung Cancer Metastasis Through the Systemic Activation of SDF-1/CXCR4 Axis
15:00 - 15:05 | Presenter: Giulia Bertolini | Author(s): Valeria Cancila, Claudio Tripodo, Gabriella Sozzi, Giuseppe Lo Russo, Orazio Fortunato, Massimo Milione, Giovanni Centonze, Monica Tortoreto, Stefania Scala, Luca Roz
- Abstract
Loading... -
+
MA13.10 - A Phase II Study of Carboplatin and Nab-Paclitaxel for Advanced Non-Small Cell Lung Cancer with Interstitial Lung Disease (HOT1302)
15:05 - 15:10 | Presenter: Hiroshi Yokouchi | Author(s): Hajime Asahina, Satoshi Oizumi, Kei Takamura, Toshiyuki Harada, Masao Harada, Kenya Kanazawa, Yuka Fujita, Tetsuya Kojima, Fumiko Sugaya, Hisashi Tanaka, Ryoichi Honda, Takahiro Ogi, Eiki Kikuchi, Tomoo Ikari, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura
- Abstract
Loading... -
+
MA13.11 - A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
15:10 - 15:15 | Presenter: Yi-Long Wu | Author(s): Baohui Han, Meiqi Shi, Haiyan Tu, Aiqin Gu, Cheng Huang, Huijuan Wang, Zhuang Yu, Xiuwen Wang, Lejie Cao, Yongqian Shu, Huaqing Wang, Runxiang Yang, Xingya Li, Jianhua Chang, Yanping Hu, Peng Shen, Yi Hu, Zhongliang Guo, Min Tao, Yiping Zhang, Xunyan Liu, Qian Sun, Xin Zhang, Zuguang Jiang, Junhui Zhao, Feng Chen, Jing Sun, Duan Li, Jinsong Zhou
- Abstract
Loading... -
+
MA13.12 - Discussant - MA13.09, MA13.10, MA13.11
15:15 - 15:30 | Presenter: Lyudmila Bazhenova
- Abstract
No abstract available for this presentation
-
+
MS07 - Controversies with Stereotactic Radiation in Early Stage Lung Cancer
- 14:00 - 15:30
- 9/09/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Laureano Molins, Salvador Villa
-
+
MS07.01 - Preoperative Optimazition: Reducing Surgery Complications Through Tobacco Cessation
14:00 - 14:10 | Presenter: David Harpole
- Abstract
Loading... -
+
MS07.02 - Post SBRT Management: Surgery
14:10 - 14:20 | Presenter: Mara Antonoff
- Abstract
Loading... -
+
MS07.03 - Post SBRT Management: vs Radiation
14:20 - 14:30 | Presenter: Marco Trovo
- Abstract
Loading... -
+
MS07.04 - Stage I (Resectable) NSCLC: Surgery
14:30 - 14:40 | Presenter: Ryota Tanaka
- Abstract
Loading... -
+
MS07.05 - Stage I (Resectable) NSCLC: Radiation
14:40 - 14:50 | Presenter: Suresh Senan
- Abstract
Loading... -
+
MS07.06 - Hot Topics in SBRT - Biopsy, Central Lesions, Radiologic Evaluation
14:50 - 15:00 | Presenter: Cecile Le Pechoux | Author(s): Angela Botticella, Antonin Levy, Olivier Henry, Isabelle Chabert, CAROLINE Caramella
- Abstract
Loading... -
+
MS07.07 - Q&A
15:00 - 15:30
- Abstract
No abstract available for this presentation
-
+
MS08 - Management of Thymic Carcinoma
- 14:00 - 15:30
- 9/09/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Thymoma/Other Thoracic Malignancies
- Moderators:Enrico Ruffini, Giovannella Palmieri
-
+
MS08.01 - Adjuvant Radiotherapy for Resected Thymic Carcinoma
14:00 - 14:15 | Presenter: Anthony Brade
- Abstract
Loading... -
+
MS08.02 - Induction Therapy for Locally Advanced Thymic Carcinoma
14:15 - 14:30 | Presenter: Robert Korst
- Abstract
Loading... -
+
MS08.03 - Optimal Management of Metastatic Thymic Carcinoma
14:30 - 14:45 | Presenter: Guiseppe Giaccone
- Abstract
Loading... -
+
MS08.04 - Novel Biomarkers for Thymic Carcinoma
14:45 - 15:00 | Presenter: Mirella Marino | Author(s): Beatrice Casini, Enzo Gallo, Enrico Melis, Fabiana Letizia Cecere, Valentina Laquintana, Virna Cerasoli, Francesco Facciolo, Edoardo Pescarmona, Francesco Fazi
- Abstract
Loading... -
+
MS08.05 - Basic Pathological Features
15:00 - 15:15 | Presenter: Cesar Moran
- Abstract
Loading... -
+
MS08.06 - Q&A
15:15 - 15:30
- Abstract
No abstract available for this presentation
-
+
MS09 - Immunotherapy in Small Cell Lung Cancer
- 14:00 - 15:30
- 9/09/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
- Moderators:Alejandro Navarro, Edurne Arriola
-
+
Introduction/Poll
14:00 - 14:00
- Abstract
No abstract available for this presentation
-
+
MS09.01 - Immune Checkpoint Blockade for SCLC: State of the Art
14:00 - 14:20 | Presenter: Scott J. Antonia
- Abstract
Loading... -
+
MS09.02 - Clincal and Molecular Biomarkers for Selection of Sclc Patients Candidate to Immunecheckpoint Blockade
14:20 - 14:40 | Presenter: Lauren Averett Byers
- Abstract
Loading... -
+
MS09.03 - Small Cell Lung Cancer: The Immune Microenvironment
14:40 - 15:00 | Presenter: Stephen V. Liu
- Abstract
Loading... -
+
MS09.04 - Q&A
15:00 - 15:30
- Abstract
No abstract available for this presentation
-
+
MTE01 - Meet the JTO Editor
- 14:00 - 15:30
- 9/09/2019
- Location: Amsterdam (2011)
- Type: Educational Session
- Track:
-
+
MTE01.01 - Meet the Editor
14:00 - 15:30 | Presenter: Alex A Adjei
- Abstract
No abstract available for this presentation
-
+
OA10 - Sophisticated TNM Staging System for Lung Cancer
- 14:00 - 15:30
- 9/09/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Oral Session
- Track: Staging
- Moderators:Ke-Neng Chen, Pedro Lopez De Castro
-
+
OA10.01 - Impact of Pre-Ordered Staging Tests on Timeliness of Lung Cancer Diagnosis and Staging: A Quality Improvement Initiative
14:00 - 14:10 | Presenter: Monica Lynn Laginha Mullin | Author(s): Audrey Tran, Christine Noseworthy, Christopher J. L. Stone, Christopher M Parker, Genevieve C Digby
- Abstract
Loading... -
+
OA10.02 - Recommended Change for N Descriptor Proposed by the IASLC: A Validation Study from a Single-Center Experience
14:10 - 14:20 | Presenter: Byung Jo Park | Author(s): Tae Ho Kim, Sumin Shin, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim, Jong Ho Cho
- Abstract
Loading... -
+
OA10.03 - Macroscore: A Prognostic Model for Supplementing the TNM Stage in Resectable Non–Small Cell Lung Cancer
14:20 - 14:30 | Presenter: Rui Mao | Author(s): Mu Li, Chang Chen, Ran Wang, Haoyue Guo, Jiani Gao
- Abstract
Loading... -
+
OA10.04 - Discussant - OA10.01, OA10.02, OA10.03
14:30 - 14:40 | Presenter: Valerie W. Rusch
- Abstract
No abstract available for this presentation
-
+
OA10.05 - Which Is Better for TNM Stage Assessment Among Whole-Body MRI and PET/MRI at 1.5 Tesla and 3 Tesla and FDG-PET/CT in Non-Small Cell Lung Cancer?
14:40 - 14:50 | Presenter: Yoshiharu Ohno | Author(s): Kota Aoyagi, Masao Yui, Daisuke Takenaka, Takeshi Yoshikawa
- Abstract
Loading... -
+
OA10.06 - Transition Patterns Between N1 and N2 Stations Discovered from Data-Driven Lymphatic Metastasis Study in Non-Small Cell Lung Cancer
14:50 - 15:00 | Presenter: Xing Wang | Author(s): Nan Wu, Qitian Chen, Xiang Li, Quanzheng Li
- Abstract
Loading... -
+
OA10.07 - Concordance Between ROSE and Final Diagnosis in Patients Undergoing EBUS- TBNA for Non-Small Cell Lung Cancer Staging
15:00 - 15:10 | Presenter: Cristina Caupena Auledas | Author(s): Mireia Martinez Palau, Bruno García Cabo, Teodora Pribic, Lluis Esteban Tejero, Francisco Perez Ochoa, Raquel Albero Gonzalez, Carme Ferrer Cassado, Pilar Forcada Guiu, Sandra Patricia Pontes De Sousa, Xavier Tarroch Sarasa, Jose Sanz Santos
- Abstract
Loading... -
+
OA10.08 - Discussant - OA10.05, OA10.06, OA10.07
15:10 - 15:20 | Presenter: Akif Turna
- Abstract
No abstract available for this presentation
-
+
OA10.09 - Clifton F. Mountain Lectureship Award for Staging
15:20 - 15:30 | Presenter: Paula Antonia Ugalde
- Abstract
No abstract available for this presentation
-
+
OA11 - Decomplexifying Molecular Targets, Immunotherapy and Treatment Settings in the Real World
- 14:00 - 15:30
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Kumar Prabhash, Jyoti D Patel
-
+
OA11.01 - Complex EGFR Mutations in Lung Adenocarcinoma
14:00 - 14:10 | Presenter: Shang-Gin Wu | Author(s): Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih
- Abstract
Loading... -
+
OA11.02 - Changes of Brain Structure in Advanced NSCLC Patients Receiving EGFR-TKIs: Dynamic Analysis Based on Series MRI Images
14:10 - 14:20 | Presenter: Chunli Luo | Author(s): Beisheng Yang, Xiaojuan Zhou, Lin Zhou, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
- Abstract
Loading... -
+
OA11.03 - Survival Disparities Between Academic and Community Centers in Advanced Lung Cancer in the US: Can We Bridge the Gap?
14:20 - 14:30 | Presenter: Sendilnathan Ramalingam | Author(s): Michaela Dinan, Jeffrey Crawford
- Abstract
Loading... -
+
OA11.04 - Discussant - OA11.01, OA11.02, OA11.03
14:30 - 14:45 | Presenter: Joel W Neal
- Abstract
No abstract available for this presentation
-
+
OA11.05 - Optimizing Resources with Immunotherapy in Developing Countries: Experience in a Reference Center in Mexico
14:45 - 14:55 | Presenter: Omar Eleazar Macedo-Perez | Author(s): Ivan Lyra Gonzalez, Leticia Bornstein, Katya Campos-Peralta, Jose Luis Aguilar-Ponce, Adan Gomez-Ponce, Angel Herrera-Gomez, Edgardo Jimenez-Fuentes
- Abstract
Loading... -
+
OA11.06 - Alternative Nivolumab (N) Duration and Scheduling in Advanced Non-Small Cell Lung Cancer (aNSCLC): Real-Life Data
14:55 - 15:05 | Presenter: Elizabeth Dudnik | Author(s): Mor Tal Moskovitz, Abed Agbarya, Teodor Kuznetsov, Tzippy Shochat, Damien Urban, Mijana Wollner, Alona Zer, Ofer Rotem, Nir Peled, Jair Bar
- Abstract
Loading... -
+
OA11.07 - Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for EGFR Mutation NSCLC Patients: Update Data for NCT02148380
15:05 - 15:15 | Presenter: Wei Zhang | Author(s): Jianlin Xu, Yuqing Lou, Yanwei Zhang, Baohui Han
- Abstract
Loading... -
+
OA11.08 - Discussant - OA11.05, OA11.06, OA11.07
15:15 - 15:30 | Presenter: Ullas Batra
- Abstract
No abstract available for this presentation
-
+
PC02 - Combining with Chemo: Old School Is New Again
- 14:00 - 15:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Advanced NSCLC
- Moderators:Julien Mazieres, Javier De Castro Carpeno
-
+
PC02.01 - TKIs Should Be Given as Single Agent
14:00 - 14:20 | Presenter: Tony Mok
- Abstract
No abstract available for this presentation
-
+
PC02.02 - TKIs Should Be Given with Chemo
14:20 - 14:40 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
PC02.03 - IO Should Be Given as a Single Agent
14:40 - 15:00 | Presenter: Julie R Brahmer
- Abstract
Loading... -
+
PC02.04 - IO Should Be Given with Chemo
15:00 - 15:20 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
PC02.05 - Q&A
15:20 - 15:30
- Abstract
No abstract available for this presentation
-
+
WS04 - Staging Workshop Part 1: IASLC Database Challenges and Application
- 14:00 - 15:30
- 9/09/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Workshop
- Track: Staging
- Moderators:Paula Antonia Ugalde, Maria Teresa Tsukazan
-
+
WS04.01 - Challenges of Data Entry in IASLC Database
14:00 - 14:10 | Presenter: Brigitte Fournier
- Abstract
Loading... -
+
WS04.02 - Challenges in Imaging Evaluation to Enter Data in the IASLC Database
14:10 - 14:20 | Presenter: Helmut Prosch
- Abstract
Loading... -
+
WS04.03 - How to Adjust Pathology Evaluation According to IASLC Database
14:20 - 14:30 | Presenter: Philippe Joubert
- Abstract
Loading... -
+
WS04.04 - Institutional Benefits of Adherence to IASLC Database
14:30 - 14:40 | Presenter: Catherine Labbe
- Abstract
Loading... -
+
WS04.05 - Developing the IASLC Lung Cancer Staging Database and Recommendations for the 9th Edition
14:40 - 14:50 | Presenter: Dorothy Jane Giroux | Author(s): Hisao Asamura, Paula Antonia Ugalde
- Abstract
Loading... -
+
WS04.06 - Case Discussion
14:50 - 15:00 | Presenter: Paula Antonia Ugalde
- Abstract
Loading... -
+
WS04.07 - Q&A
15:00 - 15:15
- Abstract
No abstract available for this presentation
-
+
ES21 - Current Strategies to Improve Outcome of Patients with Oligometastatic NSCLC
- 15:45 - 17:15
- 9/09/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Educational Session
- Track: Oligometastatic NSCLC
- Moderators:Ernest Nadal, Francoise Mornex
-
+
ES21.01 - Optimal Imaging for Staging of OMD
15:45 - 16:00 | Presenter: Klaus L. Irion | Author(s): Bruno Hochhegger
- Abstract
Loading... -
+
ES21.02 - Biological Disease Characterization of OMD
16:00 - 16:15 | Presenter: David E. Gerber
- Abstract
Loading... -
+
ES21.03 - Interpreting the Current Data for Local Consolidative Treatment in the Setting of Oligometastatic Disease: Where Do We Stand?
16:15 - 16:30 | Presenter: Daniel Gomez
- Abstract
Loading... -
+
ES21.04 - Optimal Systemic Treatment of OMD
16:30 - 16:45 | Presenter: Hideo Kunitoh
- Abstract
Loading... -
+
ES21.05 - Clinical Trials to Advance the Field of OMD
16:45 - 17:00 | Presenter: Thierry Berghmans
- Abstract
Loading... -
+
ES21.06 - Q&A
17:00 - 17:15
- Abstract
No abstract available for this presentation